These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 373352

  • 21. Relation of diabetic control to development of microvascular complications.
    Tchobroutsky G.
    Diabetologia; 1978 Sep; 15(3):143-52. PubMed ID: 359393
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oxygen affinity of hemoglobin and peripheral nerve degeneration in experimental diabetes.
    Farber SD, Farber MO, Brewer G, Magnes CJ, Peterson RG.
    J Neurol Sci; 1991 Feb; 101(2):204-7. PubMed ID: 2033405
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Editorial: Toward prevention of diabetic microangiopathy.
    Vaisrub S.
    JAMA; 1976 Mar 15; 235(11):1148-9. PubMed ID: 946219
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Diabetic angiopathies and mucopolysaccharide metabolism].
    Shvarts LS, Paukman LI.
    Probl Endokrinol (Mosk); 1971 Mar 15; 17(1):37-41. PubMed ID: 4255799
    [No Abstract] [Full Text] [Related]

  • 29. Organic osmolytes in diabetes mellitus.
    Grunewald RW, Grunewald JM.
    Exp Nephrol; 1994 Mar 15; 2(1):18-23. PubMed ID: 8081993
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
    Yamagishi S, Imaizumi T.
    Curr Pharm Des; 2005 Mar 15; 11(18):2279-99. PubMed ID: 16022668
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The problems of tissue oxygenation in diabetes mellitus. III. The "three-in-one concept" for the development of diabetic microangiopathy and a rational approach to its prophylaxis.
    Ditzel J.
    Acta Med Scand Suppl; 1975 Mar 15; 578():69-83. PubMed ID: 1057374
    [Abstract] [Full Text] [Related]

  • 35. [The role of angiogenic growth factors in the development of diabetic complications].
    Siebert J, Reiwer-Gostomska M.
    Kardiol Pol; 2009 Jan 15; 67(1):62-4. PubMed ID: 19253193
    [No Abstract] [Full Text] [Related]

  • 36. [Growth hormone and diabetic microangiopathy].
    Passa P.
    Sem Hop; 1972 Dec 08; 48(50):3329-32. PubMed ID: 4349844
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Diabetic microangiopathy].
    García-Conde Gómez FJ.
    An R Acad Nac Med (Madr); 1986 Dec 08; 103(2):173-89. PubMed ID: 3799953
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.